*ST蓮花(600186.SH):簽署重整投資協議 確定潤通貳號為第三方重整投資人
格隆匯12月23日丨*ST蓮花(600186.SH)公佈,根據《投資框架協議》及《重整計劃》的規定,2019年12月23日,經各方共同協商確認,蓮花健康、深圳市潤通貳號投資企業(有限合夥)(“潤通貳號”)、蓮泰投資、國控集團及公司管理人共同簽署《蓮花健康產業集團股份有限公司重整案重整投資協議》,確定潤通貳號作為《重整計劃》規定的第三方重整投資人蔘與蓮花健康重整。
值得注意的是,潤通貳號股權控制關係結構如下圖:

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.